As the bulls attempt another serious comeback, the market again faces a familiar question: Are valuations still too high, or have they reac...

Indian drug giant Aurobindo Pharma is set for a major US expansion. The company has received crucial antitrust clearance from the US Federa...

The U.S. Federal Trade Commission (FTC) has mandated that Aurobindo Pharma must sell off four specific drug products. This action is a cond...

A simple observation of numbness from coca leaves led to a medical revolution. Scientists isolated cocaine, revealing its power to block pa...

Seven Rice University engineering students have launched Haast Autonomous, a startup poised to revolutionize medical logistics. Securing $1...

As of 2025-26, the focus of travel insurance claims has transformed significantly. A staggering 16,000 claims pertain to non-medical issues...

Indian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...

Indian pharma is shifting from generics to innovation. This transformation, extending to 2035, is creating significant new opportunities. C...

Kashmir Medical College in Srinagar is undergoing significant development. The institution is being equipped with advanced technology and m...

Rising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...

India's health sector has seen historic changes in the last 12 years. Accessible, affordable, and quality healthcare is now a reality for c...

India's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...

There are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...

Indian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...

The landscape of India's anti-obesity drug market has reached a point of refinement. While there are affordable generic options, their upta...

Hyderabad's Hetero Labs partners with European giant Gedeon Richter. They will jointly develop and sell Semaglutide Injection, the generic ...

India is ready to welcome high-quality global pharmaceutical products. This move is in exchange for better market access for Indian drug ex...